ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety Study of Tipranavir Co-administered With Low-dose Ritonavir (TPV/r) in Patients With Advanced HIV-1 Infection and Limited Treatment Options

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00144287
Recruitment Status : Completed
First Posted : September 5, 2005
Last Update Posted : November 5, 2013
Sponsor:
Information provided by:
Boehringer Ingelheim

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 2006
  Study Completion Date : April 2006